Agendia
People in the News at Foundation Medicine, Personalis, Agendia, BioMérieux, Genetic Signatures
Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of June 12, 2023.
The 53-gene biomarker signature showed promise in predicting immunotherapy response in high-risk triple-negative and HR-positive breast cancer.
Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer
Premium
The firm envisions marketing the 53-gene signature with its existing MammaPrint and BluePrint tests as a comprehensive platform for breast cancer treatment selection.
Agendia Offering AI-Enabled Genomic Test for Breast Cancer in Brazil as it Eyes Global Market
Premium
The firm is offering access in Brazil to a digital assay that provides genomic insights using technology developed in a collaboration with computational pathology firm Paige.
Jun 12, 2020
Dec 10, 2018
SABCS 2018 Features Molecular Diagnostics Research
Nov 16, 2018
Jul 25, 2018